Editorial Comment

The Michigan Urological Surgery Improvement Collaborative (MUSIC) program has transformed both population management and quality improvement in urology. In the current study,1 the authors address an important and timely question: do men on active surveillance pursue confirmatory testing after diagnosis of favorable-risk prostate cancer and, when they do, do they persist on active surveillance? In addition to delineating current practices in Michigan of confirmatory testing —the most common being the use of molecular classifiers (55%), followed by magnetic resonance imaging (MRI, 34%) and repeat biopsy (11%), the study also captures a snapshot of how these confirmatory tests are affecting the landscape of active surveillance.
Source: Urology - Category: Urology & Nephrology Authors: Source Type: research